Genomic Health, Inc. has launched the NoMatterMyAge Campaign. This campaign is focused on raising awareness around age bias in cancer care, including access to genomic tests for breast cancer patients. The campaign highlights key facts and statistics about genomic testing based on SEER data and treatment assumptions in younger and older patients.
This campaign highlights 3 age groups: under 40, 40-70, and over 70; and includes patient stories and advocate perspectives about age-bias in cancer care and treatment. NoMatterMyAge encourages patients, regardless of age, to get as much information as they can before making a treatment decision, including whether a genomic test may help patients and their physicians determine the best treatment plan.
Find more information at NoMatterMyAge.org.